相关实验视频

Updated: Jul 16, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

复发性脑膜瘤系统治疗的进展以及未来的挑战

Yi Li1, Jan Drappatz1

  • 1Department of Neurology and Medicine, Division of Hematology and Oncology, Center for Neuro-Oncology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Expert review of neurotherapeutics
|September 11, 2023
PubMed
概括

当手术或放射治疗失败时,正在探索针对攻击性脑膜瘤 (世卫组织II-III级) 的全身疗法. 抗VEGF疗法显示出前景,目前正在进行针对分子途径的试验.

关键词:
非典型的脑膜瘤化学疗法 化疗 化疗激素导向疗法是一种激素导向疗法.恶性脑膜瘤是一种恶性脑膜瘤.经常出现的脑膜瘤有针对性的治疗.

更多相关视频

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

457
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K